State laws regarding generic drug and interchangeable biologic substitutions vary widely in the US

According to researchers, generic drugs saved the U.S. health care system $1.7 trillion between 2007 and 2016, and biologics currently account for 2 percent of dispensed mediations and almost 40 percent of spending.  However, individual state laws regarding generic drugs and interchangeable biologics substitutions vary greatly across the United States.  Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org